This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Nicotine Dependence
Information about Nicotine Dependence: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Nicotine Dependence
Most recent studies have shown that Nicotine Dependence shares some biological mechanisms with addictive-behavior, anxiety-disorders, depressive-disorder, major-depressive-disorder, malignant-neoplasm-of-lung, malignant-neoplasms, mental-disorders, patient-dependence-on, schizophrenia, substance-related-disorders, substance-use-disorder, substance-withdrawal-syndrome, tobacco-dependence-syndrome, tobacco-use-disorder, withdrawal-sign-or-symptom.
Among the many pathways, these few ones have gauged particular interests from scientists studying Nicotine Dependence, and have been seen in publications frequently: Aging, Associative Learning, Cell Adhesion, Cell Proliferation, Cognition, Localization, Locomotion, Menopause, Methylation, Pathogenesis, Prepulse Inhibition, Reflex, Response To Nicotine, Response To Stress, Secretion, Sensitization, Startle Response, Synaptic Transmission, Translation
Quite a number of genes have been found to play important roles in Nicotine Dependence, such as BDNF, CHRNA3, CHRNA4, CHRNA5, CHRNB4, COMT, CYP2A6, DIO2, DRD2, DRD4, ERMAP, ESR1, HOMER2, NDP, NDUFB6, POMC, SLC6A3, SLC6A4, TEAD1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.